News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Panel Rejects New Use for Forest Laboratories, Inc. (JOBS) Heart Drug
January 12, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON (AP) -- Federal health advisers on Monday unanimously rejected a new use of Forest Laboratories' hypertension drug for patients at risk of heart failure.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Approvals
Biogen Bounces Back With FDA Nod for High-Dose Spinal Muscular Atrophy Drug
March 30, 2026
·
3 min read
·
Tristan Manalac
FDA
Webinar: Aligning With the FDA on a Regulatory Pathway To Avoid Decision Day Surprises
March 27, 2026
·
1 min read
·
Heather McKenzie
Government
After Speaking out of Turn, Malone Steps Down From Vaccine Committee
March 27, 2026
·
2 min read
·
Tristan Manalac
Gene therapy
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
March 27, 2026
·
2 min read
·
Tristan Manalac